Atlas Trials

A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2

Clinical trial NCT05765279 · COMPLETED

Trial details

NCT number
NCT05765279
Sponsor
Beijing Ditan Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2022-10-20
Primary completion
2022-12-06
Enrollment
281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.